Oruka Therapeutics Inc (ORKA)

Apr 17, 2025

Oruka Therapeutics (ORKA) Projected to Post Quarterly Earnings on Thursday - Defense World

Apr 17, 2025

Apr 15, 2025

Vanguard Group Inc. Purchases 1,572,853 Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA) - The AM Reporter

Apr 15, 2025

Apr 15, 2025

Vanguard Group Inc. Acquires 1,572,853 Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Apr 15, 2025

Apr 13, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Shares Acquired by Wellington Management Group LLP - Defense World

Apr 13, 2025

Apr 06, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Apr 06, 2025

Apr 02, 2025

Charles Schwab Investment Management Inc. Takes Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Apr 02, 2025

Mar 24, 2025

Contrasting Achieve Life Sciences (NASDAQ:ACHV) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Mar 24, 2025

Mar 21, 2025

Fairmount Funds Management LLC Increases Stake in Oruka Therapeu - GuruFocus

Mar 21, 2025

Mar 17, 2025

Oruka Therapeutics Reports Strong 2024 Financial Results - TipRanks

Mar 17, 2025

Mar 12, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Mar 12, 2025

Mar 11, 2025

Oruka Therapeutics at Risk: Navigating Licensing Challenges and Partner Reliance - MSN

Mar 11, 2025

Mar 11, 2025

Comparing Oruka Therapeutics (NASDAQ:ORKA) & Celldex Therapeutics (NASDAQ:CLDX) - Defense World

Mar 11, 2025

Mar 10, 2025

Oruka Therapeutics (NASDAQ:ORKA) Issues Earnings Results - MarketBeat

Mar 10, 2025

Mar 09, 2025

Oruka Therapeutics (NASDAQ:ORKA) Earns “Outperform” Rating from Wedbush - Defense World

Mar 09, 2025

Mar 08, 2025

We're Not Very Worried About Oruka Therapeutics' (NASDAQ:ORKA) Cash Burn Rate - Yahoo Finance

Mar 08, 2025

Mar 07, 2025

Sector Update: Health Care -March 07, 2025 at 03:38 pm EST - Marketscreener.com

Mar 07, 2025

Mar 07, 2025

Oruka Therapeutics Says ORKA-002 Preclinical Data Support Potential Extended Dosing Intervals - Marketscreener.com

Mar 07, 2025

Mar 07, 2025

Oruka Therapeutics: Buy Rating Backed by Strong Financials and Promising Clinical Progress - TipRanks

Mar 07, 2025

Mar 07, 2025

Oruka Therapeutics Announces Preclinical Data for ORKA-002 - GlobeNewswire

Mar 07, 2025

Mar 07, 2025

Stifel maintains Buy rating on Oruka Therapeutics stock, $49 target - Investing.com

Mar 07, 2025

Mar 07, 2025

Stifel maintains Buy rating on Oruka Therapeutics stock, $49 target By Investing.com - Investing.com Canada

Mar 07, 2025

Mar 07, 2025

Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting - The Manila Times

Mar 07, 2025

Mar 06, 2025

Oruka Therapeutics Posts Q4 Net Loss -March 06, 2025 at 05:18 pm EST - Marketscreener.com

Mar 06, 2025

Mar 06, 2025

Oruka Therapeutics reports Q4 EPS (49c), consensus (98c) - TipRanks

Mar 06, 2025

Mar 06, 2025

Oruka Therapeutics Reports 2024 Financial Results and Progress on Psoriasis Pipeline Including ORKA-001 and ORKA-002 - Nasdaq

Mar 06, 2025

Mar 06, 2025

Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mar 06, 2025

Mar 06, 2025

Can Oruka's $394M War Chest Transform Autoimmune Disease Treatment? Key Pipeline Updates - StockTitan

Mar 06, 2025

Feb 28, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Major Shareholder Acquires $106,396.06 in Stock - MarketBeat

Feb 28, 2025

Feb 28, 2025

Insider Buying: Oruka Therapeutics, Inc. (NASDAQ:ORKA) Major Shareholder Acquires 88,794 Shares of Stock - MarketBeat

Feb 28, 2025

Feb 28, 2025

Oruka Therapeutics sees $1.41 million in stock purchases by Venrock Healthcare - Investing.com South Africa

Feb 28, 2025

Feb 27, 2025

Oruka Therapeutics sees $1.41 million in stock purchases by Venrock - Investing.com South Africa

Feb 27, 2025

Feb 22, 2025

Oruka Therapeutics (ORKA) to Release Earnings on Thursday - Defense World

Feb 22, 2025

Feb 20, 2025

Contrasting Virax Biolabs Group (NASDAQ:VRAX) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Feb 20, 2025

Feb 19, 2025

Oruka Therapeutics to Present at Multiple March Investor Conferences - GlobeNewswire

Feb 19, 2025

Feb 19, 2025

Can This Clinical-Stage Biotech's March Conference Circuit Signal Major Developments? - StockTitan

Feb 19, 2025

Feb 17, 2025

Oruka Therapeutics (NASDAQ:ORKA) & Alpha Teknova (NASDAQ:TKNO) Head-To-Head Contrast - Defense World

Feb 17, 2025

Feb 15, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Feb 15, 2025

Feb 15, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Feb 15, 2025

Feb 11, 2025

HC Wainwright Reaffirms Buy Rating for Oruka Therapeutics (NASDAQ:ORKA) - MarketBeat

Feb 11, 2025

Feb 10, 2025

Financial Fitness Check: Examining Oruka Therapeutics Inc (ORKA)’s Key Ratios - The Dwinnex

Feb 10, 2025

Feb 10, 2025

Oruka Therapeutics Inc (ORKA) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle

Feb 10, 2025

Feb 09, 2025

Oruka Therapeutics (NASDAQ:ORKA) Upgraded to Strong-Buy at Wolfe Research - MarketBeat

Feb 09, 2025

Feb 08, 2025

After Falling -15.24% During The Past Week, Should You Still Buy Oruka Therapeutics Inc (NASDAQ: ORKA)? - Marketing Sentinel

Feb 08, 2025

Feb 08, 2025

Vor Biopharma Inc (NASDAQ: VOR) Stock Falling -15.06% Over A Month – Any Room For Its Value To Rise? - Marketing Sentinel

Feb 08, 2025

Feb 08, 2025

Oruka Therapeutics (NASDAQ:ORKA) Now Covered by Analysts at Wolfe Research - MarketBeat

Feb 08, 2025

Feb 07, 2025

Oruka Therapeutics (NASDAQ:ORKA) Shares Gap UpTime to Buy? - MarketBeat

Feb 07, 2025

Feb 07, 2025

Oruka Therapeutics inks exclusive license deal with Paragon - MSN

Feb 07, 2025